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OBJECTIVES This study was designed to assess the feasibility and accuracy of positron emission
tomography (PET) imaging in infants and children.
BACKGROUND Positron emission tomography is employed in adults for the evaluation of myocardial
perfusion and the detection of myocardial viability.
METHODS Perfusion and metabolism findings on PET in infants and children with suspected coronary
abnormalities (age 14 days to 12 years old, mean 3.3  4.0 years) were correlated with
findings on coronary angiography, echocardiography, and myocardial histopathology. The
segmental myocardial uptake of the flow tracer 13N-ammonia and of the glucose tracer
18F-deoxyglucose (18FDG) was graded on a five-point scale and compared with the
angiographic perfusion score, with regional wall motion, and the presence of fibrosis.
RESULTS There was an agreement of r  0.72 (p  0.05) between regional myocardial perfusion and
angiography. The correlation of histopathologic changes with normal, moderately, and
severely reduced segmental 13N-ammonia uptake was 87%, 60%, and 75%, respectively.
Segmental myocardial 18FDG uptake and histopathologic findings were concordant in 48
(79%) of 64 segments without fibrosis; absence of viability by perfusion and metabolism
imaging correlated with the presence of fibrosis in 21 (84%) of 25 segments.
CONCLUSIONS The observed agreements between the findings on PET perfusion and metabolism imaging
with those on coronary angiography, echocardiography, and histopathology support the utility
and accuracy of PET for characterizing myocardial perfusion abnormalities and viability in
pediatric patients. (J Am Coll Cardiol 2003;41:618–26) © 2003 by the American College
of Cardiology Foundation
Coronary alterations, either congenital or acquired, with
impairments of regional myocardial perfusion are an impor-
tant cause of morbidity and mortality in infants and children
(1–3). Identification of such coronary compromise, espe-
cially when associated with ischemia and potentially revers-
ible contractile dysfunction, is clinically important (4,5).
Regional myocardial perfusion defects following surgical
repair of congenital heart disease can be detected with
conventional radionuclide perfusion imaging (6,7). Visual-
ization of flow defects in the small hearts of very young
infants and children should also be possible with high
spatial resolution positron emission tomography (PET).
With PET, myocardial perfusion can be assessed with
13N-ammonia and glucose utilization with 18F-
deoxyglucose (18FDG). Use of PET is well established in
adults for the detection of coronary artery disease and for
the identification of myocardial viability (8–11). However,
despite its high spatial resolution, PET has remained
underutilized in the pediatric patient population. Therefore,
the aims of this study were to examine in infants and
children the relationship between myocardial perfusion by
PET and coronary compromise and the accuracy of PET for
the detection of viable or reversibly dysfunctional myocar-
dium in comparison with findings on coronary angiography,
echocardiography, and histopathology.
METHODS
Study design and population. Nine infants and children
(age 14 days to 12 years; mean 3.3  4.0 years, 5 female)
with coronary abnormalities were studied (Table 1). Myo-
cardial perfusion and glucose utilization were evaluated at
rest with 13N-ammonia and 18FDG and PET and left
ventricular (LV) function with two-dimensional echocardi-
ography. All patients had coronary angiography. His-
topathologic information was available either postmortem
or after cardiac transplantation. In the seven children with
prior surgical repair, the time from surgery to PET averaged
14  2 months. In all nine children, the time from PET to
cardiac transplantation or death was 45  22 days; between
PET and angiography, 6  3 days; and between PET and
echocardiography, 3  4 days. The clinical indication for
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the PET study was LV dysfunction. Seven patients had
been hospitalized because of suspected myocardial ischemia
(chest pain, ST-segment changes) and two with suspected
acute myocardial infarction (new Q waves). The studies
were performed in accordance with institutional guidelines,
approval by the Institutional Review Board and with written
parental consent.
As listed in Table 1, three of the patients had congenital
coronary abnormalities (coronary-cameral fistula in the
setting of pulmonary atresia and intact ventricular septum in
two patients, and an intramural coronary artery coursing
between the great arteries in the third patient). The remain-
ing six patients had acquired coronary abnormalities, related
in one to Kawasaki’s disease with multiple coronary aneu-
rysms and in five to postsurgical coronary abnormalities
(three with coronary stenosis following the arterial switch
operation in the neonatal period, one with a coronary
obstruction following mitral valve repair and one with
transplant vasculopathy with stenosis of the left anterior
descending coronary artery [LAD]).
PET. Each patient was sedated with oral chloral hydrate
(75 mg/kg), intravenous (IV) fentanyl (1 g/kg/h) and
midazolam (0.1 mg/kg/h), with supplemental doses as
needed. Myocardial perfusion and metabolism were evalu-
ated with standard whole body PET systems (ECAT 961
and ECAT 931, 6.5 mm full-width half-maximum, Sie-
mens/CTI, Knoxville, Tennessee). Images were recon-
structed with a Shepp-Logan filter with a cutoff frequency
of 0.3 cycles/pixel, and reoriented into horizontal and
vertical long-axis and short-axis views. Twenty-minute
transmission images were recorded for correction of photon
attenuation. Beginning 5 min after IV 13N-ammonia (0.286
mCi/kg), static images were acquired for 20 min. Forty to
50 min later, 18FDG (0.143 mCi/kg) was injected IV and
acquisition of a 30-min static image began 40 min later. To
stimulate myocardial glucose, and thus 18FDG uptake,
glucose (0.3 g/kg) was administered IV 1 h before the
18FDG injection.
Image analysis. Using the standard 17-segment model, 16
regions of interest (ROI) were assigned to the LV myocar-
dium, excluding, however, the apex because of apical thin-
ning and the potential for misalignment. In each ROI,
myocardial uptake of 13N-ammonia and of 18FDG was
graded by two observers blinded to the clinical data on a
5-point scale: 4  increased, 3  normal, 2  mildly
reduced, 1moderately reduced, and 0 severely reduced.
Each segmental score was reached by consensus between the
two readers. Myocardial segments with grade 3 13N-
ammonia uptake were considered normal, regardless of
18FDG uptake. Segments with concordantly reduced 13N-
ammonia and 18FDG uptake scores were defined as having
a blood flow-metabolism match. Segments with reduced
13N-ammonia but normal, increased, or less severely re-
duced (by at least one grade) 18FDG glucose uptake were
classified as having a blood-flow metabolism mismatch (11).
Inversely, segments with normal or increased 13N-ammonia
but reduced 18FDG glucose uptake were classified as having
a reverse blood-flow metabolism mismatch. The anterior
wall, septum, and apex were considered to be subtended by
the LAD, the lateral and posterior wall by the circumflex
(LCX), and the inferior wall by the right coronary artery
(RCA).
Echocardiography. Standard subcostal, apical, parasternal,
and suprasternal notch views were obtained with an Acuson
128 Cardiac Imager (Mountain View, California) and
recorded on standard VHS tape. Wall motion was analyzed
by consensus of two observers unaware of other clinical
findings using the same LV segmentation as applied to the
PET images and a 4-point scale: 3  normal, 2  mild
hypokinesis, 1  severe hypokinesis, and 0  akinesis/
dyskinesis.
Coronary angiography. Standard selective coronary or
aortic root angiography was performed (12). The angio-
grams were analyzed visually by consensus of two pediatric
cardiologists unaware of the other diagnostic data, applying
a 4-point composite angiographic perfusion score for coro-
nary patency and collateral circulation: 3  normal coro-
naries or good collateral flow, 2  50% to 70% coronary
stenosis with poor collateral flow, 1  70% stenosis with
poor collateral flow, and 0  complete occlusion without
collaterals (13,14).
Histopathology. Following formalin fixation, the LV was
sliced perpendicular to its long axis into a basal, mid, and
apical third. Each slice was subdivided further to yield six
sections of the LV. Transmural 2- to 3-mm thick tissue
samples, including the endocardium and epicardium, were
taken to match each of the 16 LV segments as used for
analysis of echocardiograpic and PET images. All tissue
specimens were processed routinely. Histological sections
were stained with hematoxylin and eosin and trichrome.
Each tissue specimen was examined for evidence of coagu-
lation necrosis and/or fibrosis. Based on the degree of wall
thinning and the amount of residual viable myocardium
observed by visual analysis, the following pathology grades
were used: 0  25%, 1  25% to 50%, 2  50% to 75%,
and 3  75% viable, normally appearing myocytes.
Eighty-nine tissue specimens were available for analysis.
Statistical analysis. Mean values are given with standard
deviations. For correlating perfusion and metabolism scores
with histopathologic findings and angiographic scores, lin-
Abbreviations and Acronyms
18FDG  18F-deoxyglucose
ANOVA  analysis of variance
IV  intravenous
LAD  left anterior descending artery
LCX  left circumflex coronary artery
LV  left ventricular
PET  positron emission tomography
RCA  right coronary artery
ROI  region of interest
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Table 1. Clinical and Imaging Data of the Patient Population
Patient
No. Diagnosis
Age at
Surgery Surgery
Coronary
Angiography
Echo
(Hypo-/Akinesis)
Age at
PET
Weight
at PET
(kg)
13N-ammonia
PET
(Hypoperfusion)
PET
Metabolism
PET
Mismatch
Location
1 d-TGA 6 days ASO LAD occlusion LV global 24 days 3.2 Anterior, septum,
apex, inferior
Mismatch Inferior
2 d-TGA 8 days ASO RCA stenosis LV global 2.3 mon 4.1 Inferior, posterior Mismatch Posterior
3 PA/IVS 4 days RV patch Normal Septum 5.1 mon 4.6 Anterior, septum Match None
4 d-TGA, VSD,
s/p Coart
repair, PAB
4 days ASO LAD occlusion,
RCA stenosis
Septum, inferior 1.6 mon 4.9 Septum, inferior Mismatch Lateral
5 AS, Sub-AS MS 3 yrs MVR LCX stenosis NA 3.3 yrs 8 Inferior Mismatch Inferior
6 Kawasaki’s disease — — No stenosis,
coronary
aneurysms
Normal 4.8 mon 6.5 Normal Normal None
7 HLHS 7 yrs OHT LAD stenosis Normal 10.5 yrs 33.4 Normal Match None
8 PA/IVS 3 days BTS RCA, LAD
stenosis,
PDA from
RV
Lateral 13 days 3.2 Septum, RV
freewall
Mismatch RV freewall
9 DILV, restrictive
BVF
11 yrs BVF resection,
PAB
RCA with
intramural
occlusion
LV global 
outflow
chamber
akinesis
12.4 yrs 36 Midseptum, mid
and sup RV
infarction
Match None
AS  aortic stenosis; ASO  arterial switch operation; BTS  Blalock-Taussing shunt; BVF  bulboventricular foramen; DILV  double inlet left ventricle; d-TGA  d-transposition of the great arteries; HLHS  hypoplastic left
heart syndrome; IVS  intact ventricular septum; LAD  left anterior descending artery; LCX  left circumflex artery; MVR  mitral valve replacement; NA  not available; OHT  orthotopic transplant; PA  pulmonary atresia;
PAB  pulmonary artery banding; PDA  patent ductus arteriosus; RCA  right coronary artery; RV  right ventricle; VSD  ventricular septal defect.
620
Hernandez-Pam
palonietal.
JACC
Vol.41,No.4,2003
Perfusion
and
M
yocardialViability
in
Infants
February
19,2003:618–26
ear least square regressions were used. The agreement
between modalities was evaluated with kappa statistics.
Comparison of proportions between PET, echocardiogra-
phy, and coronary angiography observations was made by
chi-square analysis. Univariate one-way analysis of variance
(ANOVA) was performed to characterize differences be-
tween segments classified according to the results of diag-
nostic methods. A p value of 0.05 was considered statis-
tically significant.
RESULTS
Myocardial perfusion and glucose metabolism images in a
1.6-month-old child with d-transposition of the great
arteries and a ventricular septal defect (Patient #4, Table 1)
are shown in Figure 1. Perfusion in the lateral wall is
normal, but 18FDG uptake is reduced (arrows). Figure 2
depicts the histology in a tissue specimen removed from the
lateral wall in the same patient.
Echocardiography and coronary angiography. The diag-
nostic quality of the echocardiographic studies was adequate
in all but one patient (Patient #5) so that regional wall
motion was analyzed in 128 segments in eight patients. Two
patients had normal wall motion (Table 1). Wall motion
was abnormal in 73 of the 128 segments. Table 2 correlates
wall motion findings and angiographic scores. Although the
correlation between the exact grades of perfusion and of wall
motion failed to achieve statistical significance, allowing one
grade disagreement resulted in a 67% agreement for all
segments. Further, when segmental wall motion scores were
averaged for each coronary artery territory, significant dif-
ferences between coronary perfusion scores and severity of
wall motion abnormalities became apparent. For example,
the angiographic score averaged 2.68  0.39 in territories
with normal wall motion, 1.17  0.47 with mild hypoki-
nesis, 0.94  0.76 for territories with severe hypokinesis,
and 1.4  0.49 in territories with akinesis/dyskinesis (p 
0.05 by ANOVA all territories with abnormal vs. territories
with normal wall motion).
Myocardial perfusion and coronary angiography. Of the
144 segments analyzed by PET and angiography, 92 re-
vealed normal perfusion (Table 2). Of these, 81 segments
(88%) were subtended by normal coronary arteries. Resting
perfusion defects were present in 52 segments. Forty-nine
(94%) of these had moderately to severely reduced perfusion
scores on PET, and all were related to different degrees of
coronary stenosis (angiographic perfusion scores from 0 to
2). The correlation between segmental angiographic and
perfusion scores was statistically significant (r  0.72; p 
0.05); further, one grade agreement between angiographic
and perfusion scores (as defined previously) was found in
88% of segments (kappa value  0.52). Accordingly, the
composite angiographic scores correlated well with PET
perfusion scores (mean angiographic score for segments
with normal perfusion, 2.76  0.35; mildly reduced, 1.4 
0.48; moderately reduced, 0.67 0.36; and severely reduced
0; ANOVA, p  0.01). When segments were grouped by
coronary artery territory, the exact agreement for the LAD,
LCX, and RCA was 62% (one-grade agreement 70%), 71%
(98%), and 74% (100%), respectively.
Figure 1. Myocardial 13N-ammonia and 18F-deoxyglucose images in
Patient #4. Short and horizontal and vertical long axis slices are shown
from top to bottom. As seen best on the short axis and the horizontal long
axis slices, highlighted by the arrows, perfusion in the lateral wall is normal,
whereas 18F-deoxyglucose uptake is diminished (“reversed blood flow
metabolism mismatch”).
Figure 2. Tissue specimen obtained from the same patient shown in Fig.
1 from the lateral wall. Note the region of patchy fibrosis in the center of
the image.
Table 2. Myocardial Perfusion by 13N-ammonia PET and
Wall Motion Analysis by 2D-Echocardiography Versus
Coronary Angiography
No
Coronary
Stenosis
Coronary
Stenosis p Value
13N-ammonia PET (n  144)
Perfusion normal 81 11 0.01
Perfusion reduced 0 52 0.01
2D-echocardiography (n  128)
Wall motion normal 36 19 0.05
Wall motion abnormal 22 51 0.05
PET  positron emission tomography.
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Myocardial perfusion and wall motion. The relationship
between regional myocardial perfusion and wall motion was
explored in the 128 myocardial segments analyzed by
echocardiography. Wall motion was normal in 58 segments.
In 55 (95%) of these, perfusion scores on PET were normal.
Conversely, of the 70 segments with any degree of abnormal
wall motion, 43 segments revealed hypoperfusion. For the
58 segments with normal wall motion perfusion, scores
averaged 2.45  0.34; for the 34 segments with mild
hypokinesis, 1.18  0.36; for the 19 segments with severe
hypokinesis, 0.95  0.41; and for the 17 with akinesis/
dyskinesis, 1.24  0.23. Figure 3 depicts perfusion and wall
motion scores, relative to the angiographic scores. For
segments with an angiographic score of 3 (i.e., normal
coronary vessel), average scores for wall motion and perfu-
sion were essentially normal. Wall motion scores were
uniformly graded as severe hypokinesis for all abnormal
angiographic perfusion scores (two or less), whereas relative
perfusion scores progressively declined with increasingly
severe angiographic scores.
Myocardial glucose utilization. Myocardial 18FDG activ-
ity concentrations and myocardial perfusion were analyzed
in 144 segments. Perfusion at rest was reduced in 43
segments. In 12 of such segments, 18FDG uptake was
maintained despite diminished perfusion, reflecting a flow
metabolism mismatch; in the remaining 31 segments,
18FDG uptake was decreased, representing a blood flow
metabolism match. Importantly, 13 (68%) of the 19 myo-
cardial segments with a more than one-grade disagreement
between angiographic and perfusion scores (perfusion con-
sidered normal despite a 70% coronary stenosis, graded as
0 or 1) demonstrated normal uptake of 18FDG.
Myocardial perfusion and histopathology. Of the 89
myocardial segments submitted to histopathology, only 25
segments revealed any degree of fibrosis. No coagulation
necrosis was observed. Seven had extensive (25% viable
myocytes) and 18 had patchy, moderately severe fibrosis
(25% to 75% viable myocytes). Of all 89 segments, 47 had
a normal perfusion score. Forty-four of these segments were
without evidence of fibrosis. The remaining 42 segments
were associated with perfusion defects. Figure 4 depicts the
relationship between the presence and absence of fibrosis
and segmental perfusion. Among the 30 myocardial seg-
ments with scores of mildly to moderately reduced perfu-
sion, only 12 presented with histological evidence of fibro-
sis. The remaining 18 segments were free of fibrosis.
Furthermore, of the 12 segments with severely reduced
perfusion, only 3 segments were without evidence of fibro-
sis. Finally, of the 47 segments with normal perfusion, only
4 segments revealed fibrosis.
Patterns of perfusion and metabolism. The histopathol-
ogy findings were further correlated with the perfusion and
18FDG metabolism scores (Table 3 and Fig. 5). Of the 64
segments with 75% viable myocytes (histopathology score
3), 49 segments (76%) were normal on PET, 12 segments
(19%) revealed a match, and 3 (5%) a mismatch. In the 12
match segments, uptake of 13N-ammonia and of 18FDG
was reduced by at least one grade. In the 25 remaining
segments with 75% viable myocytes, a match pattern was
found in 7 segments with extensive (25% viable myocytes)
and in 7 segments with moderate fibrosis (25% to 75%).
Conversely, a mismatch pattern was noted in six segments
with moderately patchy fibrosis and a reverse mismatch in
six segments of the posterolateral wall.
Figure 3. Comparison of segmental perfusion (positron emission tomography, solid bars, n  144) and segmental wall motion scores (two-dimensional
echocardiography, open bars, n  128) with the angiographic scores. NS  not significant.
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Perfusion, glucose uptake, wall motion, angiography,
and histopathology. The overall correlation between his-
topathology scores, the 18FDG, the 13N-ammonia uptake,
and the wall motion scores is illustrated in Figure 6. Mean
perfusion score progressively declines from segments with-
out fibrosis to segments with extensive fibrosis; this decline
becomes statistically significant between segments with
grade 2 and with grade 1 histopathology scores (p  0.05).
Average 18FDG uptake scores were reduced in segments
with patchy fibrosis (25% to 75% viable myocytes) relative to
segments without evidence of fibrosis. Further, average
18FDG uptake was depressed most severely in segments
with extensive fibrosis.
DISCUSSION
Noninvasive approaches have been used for the identifica-
tion of myocardial perfusion abnormalities in children with
congenital heart disease (15,16). High spatial resolution
imaging with PET has, however, remained underutilized in
pediatric patients (17). To our knowledge, this is the first
study to compare in infants and children findings on
myocardial perfusion and metabolism with PET to findings
on coronary angiography and histopathology. In adults,
identification of regional myocardial perfusion abnormali-
ties and of myocardial viability by PET has been found
clinically useful, as they contain predictive information on
the potential for improvement in regional and global LV
function after revascularization (10,11). Although no such
outcome measures were available in the current study,
perfusion defects as identified by 13N-ammonia and PET
were found to correlate with angiographic scores. Further,
there was a good correlation between segmental perfusion
and wall motion, although the severity of the segmental wall
motion abnormality did not correlate directly with the
severity of the segmental perfusion deficit. Segmental per-
fusion defects, however, correlated inversely with the degree
of myocardial fibrosis on histopathology. Finally, perfusion
metabolism mismatches as indices of myocardial viability
were present most often in segments with moderately to
severely reduced perfusion and intermediate degrees of
fibrosis (25% to 75%).
Segmental myocardial perfusion. Normal segmental per-
fusion was most frequently associated with angiographic
scores of normal or good collateral blood flow. Most
segments with reduced perfusion were subtended by coro-
nary vessels with scores reflecting stenosis and limited
collateral blood flow. However, 18% of segments subtended
by abnormal coronary arteries (11/62) demonstrated normal
perfusion. This disparity was observed in one patient (Pa-
tient #8) with an abnormal origin of the posterior descend-
ing coronary artery from the right ventricle and a second
Table 3. Tissue Characterization by PET versus Histopathology
Fibrosis
Normal or
Mismatch Match p Value
Absent 52 12 0.01
Present 6 19 0.05
PET  positron emission tomography.
Figure 4. Comparison of segmental perfusion scores to findings on histopathology. Segments with grade 3 perfusion defects (severely reduced) to segments
with normal perfusion are shown from left to right. For each bar, the open area depicts the percent of segments without fibrosis, and the solid area depicts
the percent with any degree of fibrosis on histopathology.
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patient (Patient #4) with an occluded LAD coronary artery
but with well developed collaterals to the anterior wall. In
the first patient, elevated right ventricular pressures may
have resulted in an adequate coronary driving pressure so
that myocardial perfusion at rest was essentially normal.
Had pharmacologic stress testing been performed, it might
have uncovered coronary compromise (9,18). Misalign-
ments of myocardial segments as identified on the PET
images and as designated by coronary angiography may also
account for some of the observed disparities. Such misalign-
ment could further explain disparities between segmental
perfusion and wall motion. Thus, wall motion was abnormal
in 26 of the segments with normal perfusion. Seven nor-
mally perfused segments with reduced wall motion were
subtended by coronary vessels with abnormal scores; again,
these segments would probably have revealed, flow defects
on pharmacologic stress testing.
Segmental perfusion defects were correlated with abnor-
mal angiographic scores. Although perfusion was evaluated
only at rest and would be expected to be normal in some
segments supplied by abnormal coronary arteries, in 19 of
38 hypoperfused segments available for histopathologic
correlation, various degrees of tissue fibrosis were noted. It
is thus likely that resting myocardial perfusion was reduced
as a function of the fractional amount of tissue fibrosis
(19,20). In the remaining 72% of segments without his-
topathologic evidence of fibrosis, an impairment in wall
motion and systolic thickening may have led to a partial
volume related underestimation of regional myocardial per-
fusion. In fact, 15 (71%) of the segments with reduced
perfusion but without fibrosis exhibited wall motion abnor-
malities.
Myocardial blood flow and metabolism. Coronary an-
giography provides excellent detail of the coronary anatomy,
but little if any information on myocardial viability (21).
Myocardial perfusion as assessed with 13N-ammonia and
Figure 5. Correlation between the segmental amounts (in percent) of viable or normal myocytes and the corresponding blood flow metabolism patterns on
positron emission tomography.
Figure 6. Comparisons of the mean angiographic, wall motion by echocardiography (2D-Echo), perfusion on positron emission tomography (Perfusion
PET), and metabolism by 18F-deoxyglucose on positron emission tomography (FDG PET) scores and the histopathologic grades.
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PET can provide important information on the potential
reversibility of regional myocardial dysfunction. Perfusion
alone offered information on the presence or absence of
myocardial viability. For example, myocardial segments
with normal or, conversely, with severely reduced 13N-
ammonia uptake were strongly correlated with the absence
or presence of tissue fibrosis, respectively. However, this
correlation was weaker for segments with moderately re-
duced perfusion. In most of these segments (42 of 45),
hypoperfusion was associated with abnormal wall motion.
On histopathology, however, some segments revealed tissue
fibrosis, whereas others did not. Thus, moderate reductions
in perfusion appeared to discriminate insufficiently between
reversible and irreversible regional myocardial dysfunction.
In such segments, 18FDG may aid to identify myocardial
viability. 18F-deoxyglucose-PET revealed metabolic abnor-
malities in most segments with perfusion defects. Impor-
tantly, a mismatch pattern was found in four patients with
severe coronary stenoses and wall motion abnormalities. As
depicted in Figure 6, 18FDG uptake correlated with the
amount of fibrosis, indicating that glucose metabolism is
markedly reduced in infarcted regions. Conversely, pre-
served myocardial metabolic activity in the entire LV
indicates the absence of any significant coronary stenosis. In
two children, myocardial 18FDG was normal. Neither of
these patients had evidence of any coronary stenosis or
occlusion. Interestingly, six segments demonstrated a re-
verse mismatch with preserved myocardial perfusion but
reduced metabolic activity. According to findings in post-
thrombolysis patients (22), this pattern likely reflects myo-
cardial viability.
Study limitations. A limitation to all nuclear imaging
studies in infants and children is the lack of an age-specific
database of normal findings. Ethical reasons preclude estab-
lishment of such normal databases in healthy infants and
children. Therefore, prospective studies in a larger pediatric
patient population would be needed for determining the
significance of perfusion-metabolism patterns. However, it
seems reasonable to assume that contractile function is likely
to recover in dysfunctional myocardium with little to no
fibrosis as compared with segments with 40% fibrosis that
are unlikely to improve wall motion and, thus, would be
considered “nonviable” or “irreversibly dysfunctional”
(19,20). Normal variations in tracer uptake or transient
postoperative metabolic changes without flow-limiting ste-
noses may have been related to mild hypoperfusion in some
areas unrelated to coronary lesions and perhaps attributable
to stunning (23). Further, the degree of fibrosis was not
quantitated but estimated through visual analysis. In addition,
it was not possible to precisely localize image segments.
Finally, three patients had been diagnosed with cyanotic
heart disease, raising the possibility of a hypoxia-related
effect on myocardial 18FDG uptake. However, because of
compensatory erythrocytosis, normal arterial O2 concentra-
tions, and a normal cardiac output, tissue hypoxia was
unlikely to be present in these children.
Clinical implications. The correlation between angio-
graphic and perfusion abnormalities indicates a potentially
important role of high resolution PET for noninvasively
identifying coronary abnormalities in pediatric patients. It
may be considered a valid screening tool as well as an
important adjunct to invasive angiography in selected pop-
ulations. Our study demonstrates for the first time in a
pediatric population that PET perfusion-metabolism imag-
ing can provide important information on tissue viability.
Positron emission tomography distinguished regions with
marked tissue fibrosis from myocardium free of fibrosis.
Because myocardial viability reflects potentially reversible
regional and global LV dysfunction (8,10,11,20), PET
imaging may provide clinically important information in
pediatric patients, especially when surgical correction of
coronary abnormalities is possible.
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